GB0613761D0 - A pharmaceutical formulation and method for the preparation thereof - Google Patents

A pharmaceutical formulation and method for the preparation thereof

Info

Publication number
GB0613761D0
GB0613761D0 GBGB0613761.6A GB0613761A GB0613761D0 GB 0613761 D0 GB0613761 D0 GB 0613761D0 GB 0613761 A GB0613761 A GB 0613761A GB 0613761 D0 GB0613761 D0 GB 0613761D0
Authority
GB
United Kingdom
Prior art keywords
preparation
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0613761.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Priority to GBGB0613761.6A priority Critical patent/GB0613761D0/en
Publication of GB0613761D0 publication Critical patent/GB0613761D0/en
Priority to PCT/GB2007/002609 priority patent/WO2008007099A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0613761.6A 2006-07-11 2006-07-11 A pharmaceutical formulation and method for the preparation thereof Ceased GB0613761D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0613761.6A GB0613761D0 (en) 2006-07-11 2006-07-11 A pharmaceutical formulation and method for the preparation thereof
PCT/GB2007/002609 WO2008007099A1 (en) 2006-07-11 2007-07-11 A pharmaceutical formulation comprising a beta2-selective adrenorezeptor agonist and / or glucocorticoid and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0613761.6A GB0613761D0 (en) 2006-07-11 2006-07-11 A pharmaceutical formulation and method for the preparation thereof

Publications (1)

Publication Number Publication Date
GB0613761D0 true GB0613761D0 (en) 2006-08-23

Family

ID=36955446

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0613761.6A Ceased GB0613761D0 (en) 2006-07-11 2006-07-11 A pharmaceutical formulation and method for the preparation thereof

Country Status (2)

Country Link
GB (1) GB0613761D0 (en)
WO (1) WO2008007099A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2693036C (en) 2010-02-16 2012-10-30 Imperial Oil Resources Limited Hydrate control in a cyclic solvent-dominated hydrocarbon recovery process
CN105832712A (en) * 2016-05-12 2016-08-10 河北仁合益康药业有限公司 Salbutamol sulfate solution composition for inhaling and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers

Also Published As

Publication number Publication date
WO2008007099A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
GB2450753B (en) New Pharmaceutical formulation
EP2123260A4 (en) Liposome formulation and process for preparation thereof
HK1129590A1 (en) Multiple unit type sustained release oral formulation and process for the preparation thereof
IL185390A0 (en) A solid pharmaceutical dosage formulation
GB0614586D0 (en) Pharmaceutical Formulation
ZA200901464B (en) Packaging comprising pharmaceutical forms
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
HK1135338A1 (en) A pharmaceutical composition for treating depression and method for preparation thereof
EP1753405A4 (en) Controlled release pharmaceutical formulation
EP2167468A4 (en) Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
EP2002828A4 (en) Solid pharmaceutical preparation
EP2025667A4 (en) 9,10-secopregnane derivative and pharmaceutical
IL195822A0 (en) Segmented pharmaceutical dosage forms
IL198160A0 (en) Pharmaceutical formulations
IL192844A0 (en) Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
IL195034A0 (en) Liquid pharmaceutical formulation
HK1105358A1 (en) Solid pharmaceutical formulation
GB0613761D0 (en) A pharmaceutical formulation and method for the preparation thereof
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
GB0522473D0 (en) A pharmaceutical formulation
EP1716865A4 (en) Paraoxonase-containing pharmaceutical preparation
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
ZA200810270B (en) Segmented pharmaceutical dosage forms
PL377894A1 (en) Pharmaceutical preparation and method for its obtaining

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)